Risk factors

BioAtla (BCAB) risk factors

Item 1A of every BioAtla, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open BCAB in Gloom →
BioAtla's chart, financials and news, free in your browser.Open BCAB in Gloom →
  • FY2025 10-K risk factors
    90 risks12 new4 dropped15 reworded

    The company is exploring strategic options including asset sales, restructuring with a 70% workforce reduction, and facing Nasdaq delisting threats due to minimum bid price deficits.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors
    82 risks

    BioAtla relies heavily on its unproven CAB technology platform and needs substantial capital to fund its clinical programs.

    Filed Mar 28, 2025